You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

brigatinib

( bri GA ti nib )
Other Name(s): Alunbrig™
Appearance: Tablet

Drug Monograph

Jun 2019
Table of Contents

Patient Info Sheet

Jan 2021

What it is used for

  • For treating a type of lung cancer called ALK (anaplastic lymphoma kinase)-positive lung cancer in patients whose cancer has become worse after taking or who are unable to take crizotinib.


You might also be interested in

Funding & Reimbursement

Several payment sources exist for cancer drugs in Ontario, depending on the drug, disease indication, and how and where it is delivered.

View Funding & Reimbursement

Symptom Management

Many people living with cancer experience nausea, diarrhea and other symptoms from their treatment or disease.

View Symptom Management

Drug Safety and Administration

Find documents on drug safety and administration for healthcare providers, including calculations and recommendations.

View Drug Safety and Administration